Related content

Contribution of Canalicular Glutathione Efflux to Bile Formation. From Cholestasis Associated Alterations to Pharmacological Intervention to Modify Bile Flow

By  

Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Vol. 5, Iss. 2, 2005-06 ,pp. : 153-161

Bentham Science Publishers

Access to resources Recommend Favorite

Predicting P-Glycoprotein Effects on Oral Absorption: Correlation of Transport in Caco-2 with Drug Pharmacokinetics in Wild-Type and mdr1a(-/-) Mice in Vivo

By Collett Andrew   Tanianis-Hughes Jolanta   Hallifax David   Warhurst Geoff  

Pharmaceutical Research, Vol. 21, Iss. 5, 2004-05 ,pp. : 819-826

Springer Publishing Company

Access to resources Recommend Favorite

(Section A: Molecular, Structural, and Cellular Biology of Drug Transporters) The Role of MDR1 Genetic Polymorphisms in Interindividual Variability in P-glycoprotein Expression and Function

By  

Current Drug Metabolism, Vol. 5, Iss. 1, 2004-02 ,pp. : 11-19

Bentham Science Publishers

Access to resources Recommend Favorite

Utility of Mdr1-Gene Deficient Mice in Assessing the Impact of P-glycoprotein on Pharmacokinetics and Pharmacodynamics in Drug Discovery and Development

By  

Current Drug Metabolism, Vol. 4, Iss. 4, 2003-08 ,pp. : 272-291

Bentham Science Publishers

Access to resources Recommend Favorite

Characterisation of cerivastatin as a P-glycoprotein substrate: studies in P-glycoprotein-expressing cell monolayers and mdr1a/b knock-out mice

By Kivistö Kari   Zukunft Jörg   Hofmann Ute   Niemi Mikko   Rekersbrink Sabine   Schneider Swetlana   Luippold Gerd   Schwab Matthias   Eichelbaum Michel   Fromm Martin  

Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 370, Iss. 2, 2004-08 ,pp. : 124-130

Springer Publishing Company

Access to resources Recommend Favorite